ClinicalTrials.govpublic full text
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
pancreatic cancer, pdac - pancreatic ductal adenocarcinoma, pancreas cancer, pancreatic neoplasms, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917677
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.